BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19200579)

  • 1. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.
    López-Terrada D; Gunaratne PH; Adesina AM; Pulliam J; Hoang DM; Nguyen Y; Mistretta TA; Margolin J; Finegold MJ
    Hum Pathol; 2009 Jun; 40(6):783-94. PubMed ID: 19200579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways.
    Adesina AM; Lopez-Terrada D; Wong KK; Gunaratne P; Nguyen Y; Pulliam J; Margolin J; Finegold MJ
    Hum Pathol; 2009 Jun; 40(6):843-53. PubMed ID: 19200578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study.
    Litten JB; Chen TT; Schultz R; Herman K; Comstock J; Schiffman J; Tomlinson GE; Rakheja D
    Pediatr Dev Pathol; 2011; 14(5):378-83. PubMed ID: 21639801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.
    Bell D; Ranganathan S; Tao J; Monga SP
    Gene Expr; 2017 Feb; 17(2):141-154. PubMed ID: 27938502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
    Wirths O; Waha A; Weggen S; Schirmacher P; Kühne T; Goodyer CG; Albrecht S; Von Schweinitz D; Pietsch T
    Lab Invest; 2003 Mar; 83(3):429-34. PubMed ID: 12649343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.
    Ranganathan S; Ningappa M; Ashokkumar C; Higgs BW; Min J; Sun Q; Schmitt L; Subramaniam S; Hakonarson H; Sindhi R
    Sci Rep; 2016 Dec; 6():38347. PubMed ID: 27910913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
    Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
    Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Catenin and met deregulation in childhood Hepatoblastomas.
    Ranganathan S; Tan X; Monga SP
    Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.
    Curia MC; Zuckermann M; De Lellis L; Catalano T; Lattanzio R; Aceto G; Veschi S; Cama A; Otte JB; Piantelli M; Mariani-Costantini R; Cetta F; Battista P
    Mod Pathol; 2008 Jan; 21(1):7-14. PubMed ID: 17962810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.
    Fasano M; Theise ND; Nalesnik M; Goswami S; Garcia de Davila MT; Finegold MJ; Greco MA
    Mod Pathol; 1998 Oct; 11(10):934-8. PubMed ID: 9796718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
    Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
    Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma.
    Halász J; Holczbauer A; Páska C; Kovács M; Benyó G; Verebély T; Schaff Z; Kiss A
    Hum Pathol; 2006 May; 37(5):555-61. PubMed ID: 16647953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
    Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
    Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
    Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
    Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
    Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
    Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.
    Park WS; Oh RR; Park JY; Kim PJ; Shin MS; Lee JH; Kim HS; Lee SH; Kim SY; Park YG; An WG; Kim HS; Jang JJ; Yoo NJ; Lee JY
    J Pathol; 2001 Apr; 193(4):483-90. PubMed ID: 11276007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.